Cristiano Noto

Cristiano Noto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cristiano Noto has a total of 258 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Early psychosis care in Brazil: a comparative study of a specialized university center and community-based services

    by Pâmela Pilar, July Gomes, Ary Gadelha, Cristiano Noto

    The Brazilian Journal of Psychiatry is the official publication of Brazilian Psychiatric Association (Associação Brasileira de Psiquiatria - ABP)


  • Open Access

    Peer-Mediated Cognitive Enrichment in First-Episode Psychosis: A Pilot Feasibility Study Using the Feuerstein Approach

    by Ana Olivia Fonseca, July Silveira Gomes, Maria Eva de Miranda Alves Rodrigues, Ary Gadelha, Cristiano Noto

    Background : Translating cognitive remediation gains into everyday functioning remains limited in schizophrenia. We evaluated a peer-mediated Feuerstein Instrumental Enrichment (FIE) approach, grounded in mediated learning principles, in individuals in the early phase of illness. The FIE approach utilizes small-group sessions, mediator oversight, and explicitly guided transfer strategies to promote metacognitive reflection and strengthen real-world generalization. Objective : This pilot study aimed to assess the feasibility and acceptability of a peer-mediated FIE program in first-episode psychosis (FEP) and to generate preliminary signals of its effect on patient-centered functional outcomes. Methods : In this open-label, single-arm pilot study, 16 individuals with FEP participated in a 10-week, group-based FIE program. Outcomes were assessed at baseline (T0), post-intervention (T1), and 6-month follow-up (T2). The primary outcome was patient-centered functioning, measured by the Goal Attainment Scale (GAS). Secondary outcomes included cognitive domains (MCCB) and symptom severity (PANSS). Change over time were analyzed using the non-parametric Friedman test. Results : The intervention demonstrated excellent feasibility, with 100% participant retention. Significant and sustained improvements were observed in patient-defined functional goals (GAS; χ2(2)=24.43, p<.001). Additionally, preliminary cognitive gains emerged in Processing Speed, as measured by the Coding subtest (χ2(2)=10.47, p<.005), and in Verbal Working Memory, assessed by the Letter–Number Span (χ2(2)=10.34, p<.006), suggesting domain-specific enhancement of cognitive efficiency and working memory manipulation. Furthermore, significant reductions were noted in positive, general, and total PANSS scores, while negative symptoms remained stable. Conclusions : Peer-mediated FIE is a highly feasible and acceptable intervention for individuals with FEP. The promising preliminary signals on patient-centered functioning and specific cognitive domains strongly support the need for a large-scale randomized controlled trial with an active control group to definitively establish efficacy.

  • Toxoplasmosis infection and schizophrenia: Elevated IgM reactivity index as a predictor of symptom worsening in chronic schizophrenia

    by Pedro H.P. Alvim, Victoria C. Cavalari, Ana J. Bianchini, Gabriela Ferreira Frizon, Gabriela Mourao Ferreira, Helena Fabiane Huth Savian, Isabela Drehmer, Jéferson Ferraz Goularte, Luiz F.C. Garcia, Marcelo Carriello, et al.


  • Open Access

    A hybrid model for predicting response to risperidone after first-episode psychosis

    by Giovany Oliveira Costa, Vanessa K. Ota, Matheus Rodrigues Luiz, Joice Santos Rosa, Gabriela Xavier, Jessica Honorato-Mauer, Marcos L. Santoro, Carolina Muniz Carvalho, Daniel A. Cavalcante, Amanda V. G. Bugiga, et al.

    The Brazilian Journal of Psychiatry is the official publication of Brazilian Psychiatric Association (Associação Brasileira de Psiquiatria - ABP)


  • Open Access

    Feuerstein Instrumental Enrichment Program for People With Schizophrenia After the First Episode of Psychosis: Protocol for an Open-Label Intervention Study

    by Ana Olivia Fonseca, July Silveira Gomes, Rafael Angulo Condoretti Barros Novaes, Cíntia Lopes Dias, Maria Eva de Miranda Alves Rodrigues, Ary Gadelha, Cristiano Noto

    Background: Schizophrenia is a disorder associated with neurocognitive deficits that adversely affect daily functioning and impose an economic burden. Cognitive rehabilitation interventions, particularly during the early phases of illness, have been shown to improve cognition, functionality, and quality of life. The Feuerstein Instrumental Enrichment (FIE) program, based on the Mediated Learning Experience and the Structural Cognitive Modifiability theory, has been applied in various disorders, but its applicability in schizophrenia has not yet been clarified. Objective: This study aims to investigate the effects of the FIE program on the functionality of patients with first-episode schizophrenia. Methods: In total, 17 patients will be recruited for an open-label intervention consisting of twice-weekly sessions for 10 weeks. The primary outcome measure will be changes in the Goal Achievement Scale score. Maze task performance from the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) battery will serve as a secondary outcome measure. At the same time, changes in Positive and Negative Syndrome Scale scores and other MATRICS domains will be analyzed as exploratory outcomes. Assessments will be administered before and after the intervention, with a follow-up period of 6 months. Results: This trial was preregistered in The Brazilian Registry of Clinical Trials (RBR-4gzhy4s). By February 2024, 11 participants were enrolled in the training. Recruitment is expected to be completed by May 2024. Data analysis will be conducted between May and September 2024. The results are expected to be published in January 2025. Conclusions: This study may establish a protocol for the FIE program that uses mediation techniques for individuals in the early stages of schizophrenia. The results will add to the knowledge about strategies to promote cognitive skills and functional impairment in daily life. International Registered Report Identifier (IRRID): DERR1-10.2196/57031


  • GAPi: A description of the initiative for early psychosis intervention in Latin America and the short- to medium-term outcomes in early psychosis patients

    by Daniel A. Cavalcante, Mariane Noto, Raphael de O. Cerqueira, Giovany Oliveira Costa, Luccas Coutinho, Fernando Malinovski, Ana Olívia Fonseca, Marcos Leite Santoro, Vanessa Ota, Quirino Cordeiro, et al.


  • Open Access

    Feuerstein Instrumental Enrichment Program for People With Schizophrenia After the First Episode of Psychosis: Protocol for an Open-Label Intervention Study (Preprint)

    by Ana Olivia Fonseca, July Silveira Gomes, Rafael Angulo Condoretti Barros Novaes, Cíntia Lopes Dias, Maria Eva de Miranda Alves Rodrigues, Ary Gadelha, Cristiano Noto

    BACKGROUND Schizophrenia is a disorder associated with neurocognitive deficits that adversely affect daily functioning and impose an economic burden. Cognitive rehabilitation interventions, particularly during the early phases of illness, have been shown to improve cognition, functionality, and quality of life. The Feuerstein Instrumental Enrichment (FIE) program, based on the Mediated Learning Experience and the Structural Cognitive Modifiability theory, has been applied in various disorders, but its applicability in schizophrenia has not yet been clarified. OBJECTIVE This study aims to investigate the effects of the FIE program on the functionality of patients with first-episode schizophrenia. METHODS In total, 17 patients will be recruited for an open-label intervention consisting of twice-weekly sessions for 10 weeks. The primary outcome measure will be changes in the Goal Achievement Scale score. Maze task performance from the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) battery will serve as a secondary outcome measure. At the same time, changes in Positive and Negative Syndrome Scale scores and other MATRICS domains will be analyzed as exploratory outcomes. Assessments will be administered before and after the intervention, with a follow-up period of 6 months. RESULTS This trial was preregistered in The Brazilian Registry of Clinical Trials (RBR-4gzhy4s). By February 2024, 11 participants were enrolled in the training. Recruitment is expected to be completed by May 2024. Data analysis will be conducted between May and September 2024. The results are expected to be published in January 2025. CONCLUSIONS This study may establish a protocol for the FIE program that uses mediation techniques for individuals in the early stages of schizophrenia. The results will add to the knowledge about strategies to promote cognitive skills and functional impairment in daily life. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/57031

  • Open Access

    Negative dimension stability across clinical stages and sociodemographic characteristics in schizophrenia

    by Gabriela Koga, Bernardo Haguiara, Bruno Ortiz, Cristiano Noto, Rosana Ramos Freitas, Helio Elkis, Rodrigo Bressan, Carolina Ziebold, Ary Gadelha

  • Unraveiling the correlation among neurodevelopmental and inflammatory biomarkers in patients with chronic schizophrenia

    by João V. Nani, Priscila G. C Almeida, Cristiano Noto, Rodrigo A. Bressan, Elisa Brietzke, Mirian A. F Hayashi

    Nuclear distribution element like-1 (Ndel1) is a cytosolic oligopeptidase, which was suggested as a potential biomarker of aberrant neurodevelopment and early stage of schizophrenia (SCZ). The invo...


  • Open Access

    Clozapine prescription trends in Brazil in the last decade

    by Raffael Massuda, Clarissa S. Gama, Paulo Belmonte-De-Abreu, Helio Elkis, David Freitas de Lucena, Rodrigo Bressan, Cristiano Noto, Ary Gadelha

    Objective: Clozapine is a second-generation antipsychotic indicated for treatment-resistant schizophrenia. Studies in several countries have shown a low rate of clozapine use despite the fact that approximately 30% of schizophrenia cases are treatment-resistant. In Brazil, few studies have addressed the frequency and variety of antipsychotic use in individuals diagnosed with schizophrenia (ICD F20). The objective of this study was to measure the rates of clozapine use in this population in the last decade using Brazilian Ministry of Health data.Methods: Prescriptions made between 2010 and 2020 in all 26 states and the Federal District registered at the Outpatient Information System Database from the Brazilian Health System (SIASUS) were evaluated.Results: A total of 25,143,524 prescriptions were recorded in this period, with clozapine representing 8.86% of all antipsychotics. The most frequently prescribed antipsychotic for patients with schizophrenia was olanzapine (35.8%), followed by quetiapine (27.5%). From 2010 to 2020, the rate of clozapine prescriptions in Brazil increased from 7.2% to 10.9%.Conclusions: Despite a slight increase in prescriptions in the last decade, clozapine is still underutilized in Brazil.